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Abstract Machado^Joseph disease (MJD)/spinocerebellar
ataxia type 3 is an autosomal dominant spinocerebellar degen-
eration characterized by a wide range of clinical manifestations.
Unstable CAG trinucleotide repeat expansion in the MJD gene
has been identi¢ed as the pathologic mutation of MJD. In this
study, human SK-N-SH neuroblastoma cells stably transfected
with full-length MJD with 78 CAG repeats were established.
Compared with the parental cells, cells expressing mutant atax-
in-3 displayed normal morphology for over 80 generations. Less
than 1% of the transfected cells contained nuclear aggregates
under basal conditions, indicating that this cellular model rep-
resented an early disease stage. While t-butyl hydroperoxide
(TBH) was used to assess the oxidative tolerance of cells, the
results demonstrated that the transfected cells were more sus-
ceptible to low concentrations of TBH than the parental cells.
Most interestingly, from 2D gel electrophoresis analysis, we
identi¢ed that the expression of heat shock protein 27
(HSP27), known as a suppressor of poly(Q)-mediated cell
death, dramatically decreased in SK-N-SH cells stably trans-
fected with full-length mutant MJD. The same reduction of
HSP27 was further con¢rmed in lymphoblastoid cells from
MJD patients. Our results demonstrated that both neuronal
and non-neuronal cells with expanded full-length ataxin-3 re-
vealed reduced protein expression of HSP27. We propose that
the reduction of HSP27 in the early stage of the disease plays
an important role during cell death process in MJD.
; 2003 Federation of European Biochemical Societies. Pub-
lished by Elsevier Science B.V. All rights reserved.
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1. Introduction
Machado^Joseph disease (MJD) belongs to a special class
of inherited neurodegenerative disease caused by CAG trinu-
cleotide repeat expansion in the coding region of the respec-
tive genes [1,2]. In all cases, the CAG repeats are transcribed
and translated into polyglutamine tracts [3]. Clinically, MJD
is characterized by progressive ataxia in combination with
various non-cerebellar symptoms, including oculomotor ab-
normalities, spasticity, basal ganglia symptoms, peripheral
neuropathy and cognitive disturbances [4,5]. All MJD-a¡ected
patients exhibit expanded CAG’s with 55^84 repeats whereas
normal individuals exhibit 13^51 repeats [6]. Polyglutamine
diseases are dominantly inherited, typically late-onset, fatal
neurodegenerative disorders. The protein is widely expressed
in neurons [7] and outside the central nervous system, but the
mutation ultimately leads to selective neuronal loss in re-
stricted brain regions. The nature of the toxic insult of a
poly(Q) mutation and its biological consequences in each dis-
ease are unclear. It is possible that the poly(Q) expansion
interferes with basic cellular process such as transcription,
protein degradation and survival/death signaling [8]. It was
shown that the ataxin-3 accumulated in ubiquitinated intra-
nuclear inclusions selectively in neurons of a¡ected brain re-
gions [9]. Neuronal intranuclear inclusions have become the
neuropathological sign of the CAG repeat diseases, but their
cytotoxicity still remained controversy [10].
The mechanism that leads the polyglutamine-expanded pro-
teins to aggregate is unknown. There is a possibility that the
extended polyglutamine tract may destabilize the protein to
misfold and aggregate. Indeed, in spinocerebellar ataxia type 3
(SCA3) brain, heat shock protein 40 (HSP40) and HSP70
were found to localize to nuclear inclusions (NIs) [11]. In
addition, di¡erent HSPs have been shown to directly inhibit
several types of cell death pathways induced by a variety of
toxic insults in neuronal cells [12^15]. HSP27 was reported to
have anti-apoptotic properties in neuronal survival [16,17].
The expression of HSP27 was shown to enhance the survival
of mammalian cells exposed to a number of cytotoxic agents,
including heat shock, oxidative stress, chemotherapeutic
agents, and cytokines [18^21]. In addition, oxidative stress
induced by reactive oxygen species (ROS) or free radicals
played an important role in the pathogenesis of several neu-
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rodegenerative disorders including Alzheimer’s disease [22],
Huntington disease and other late-onset neurodegenerative
conditions [23]. Recently, it was reported that overexpression
of HSP27 prevented cellular polyglutamine toxicity and sup-
pressed the increase levels of cellular ROS caused by hunting-
tin [24]. However, the mechanisms of how HSP27 involved in
the pathogenesis of MJD remained unclear.
In cells transiently transfected with expanded ataxin-3 and
in the human SCA3 brain tissue, transcription factors CBP
(cAMP response element-binding protein-binding protein)
and TBP (TATA-binding protein) were recruited into NIs,
pointing to a direct interaction of the expanded ataxin-3
with speci¢c transcription factors [25,26]. In addition, rate
mesencephalic CSM14.1 cells stably expressing expanded
ataxin-3 resulted in the up-regulation of some in£ammatory
genes in the late stage of the disease [27]. However, to our best
knowledge, no human neuronal cells expressing full-length
mutant ataxin-3 were previously reported. In the present
study, we established SK-N-SH neuroblastoma cells stably
expressing anti-hemagglutinin (HA)-tagged full-length MJD
with 78 CAG repeats to examine the e¡ects of expanded atax-
in-3 under normal conditions and oxidative stress. Our results
showed that only less than 1% of the mutant cells contained
nuclear aggregates under basal growth conditions. Stably
transfected cells were more sensitive to low concentrations
of t-butyl hydroperoxide (TBH), indicating that transfected
cells were more susceptible to the toxic insult than cells with-
out mutant ataxin-3. Most interestingly, we demonstrated that
the protein levels of HSP27 dramatically decreased in cells
with expanded ataxin-3, which may signi¢cantly impair the
protection ability of the cells to respond to stress and ulti-
mately lead to stress-induced cell death.
2. Materials and methods
2.1. Materials
SK-N-SH cells were provided by Dr. Shin-Lan Hsu (Taichung Vet-
erans General Hospital, Taiwan). All culturing supplies and transfec-
tion materials were obtained from Gibco Life Technologies (Gaithers-
burg, MD, USA). Western blot reagents were obtained from Pierce
(Rockford, IL, USA). Mouse monoclonal anti-MJD was made pre-
viously [28]. Mouse monoclonal anti-HSP27 was from Lab Vision
(Fremont, CA, USA). Monoclonal anti-L-actin was from Sigma (St.
Louis, MO, USA). Mouse monoclonal HA epitope was from Roche
Molecular Biochemicals (Mannheim, Germany). Rabbit polyclonal
HA epitope was from Santa Cruz Biotechnology (Santa Cruz, CA,
USA). All other supplies were obtained from Sigma Chemical (St.
Louis, MO, USA).
2.2. Generation of stably transfected MJD cells
Neuronal SK-N-SH cells were grown in Dulbecco’s modi¢ed Ea-
gle’s medium (DMEM) containing 10% heat-inactivated fetal bovine
serum (FBS), 1% L-glutamine and 1% penicillin/streptomycin. Cells in
60-mm dishes, at 60^70% con£uence, were transfected using Lipofect-
amine reagent following manufacturer’s instructions. Cells were trans-
fected with 2 Wg of empty pCDNA3.1 vector or pCDNA3.1 contain-
ing full-length MJD with 78 glutamines (pCDNA3-HAMJD78, a
generous gift from Dr. Henry Paulson). Twenty-four hours after
transfection, cells were selected in culture medium supplemented
with G418 (neomycin sulfate, 500 Wg/ml). Densely growing foci of
transformed cells were trypsinized after 2 weeks and transferred to
a 6-well plastic culture dish. Transfection with the empty plasmid was
also performed as comparison. Selected G418-resistant cells were sub-
cloned and maintained in the same conditioned medium until each cell
line contained homogenous transfected cells. After 3 months of selec-
tion and subcloning, we obtained stable cells expressing expanded
ataxin-3. For all experiments, cells were placed in medium lacking
G418.
2.3. Preparation of lymphoblastoid cells
Lymphoblastoid cells from two MJD-a¡ected patients with alleles
containing 31 and 80, 16 and 79 CAG repeats, respectively, and nor-
mal control with 12 CAG repeats were established by Epstein^Barr
virus transformation. The procedure details were as described [29,30].
Cells were maintained in RPMI 1640 medium (Gibco-BRL) contain-
ing 10% FBS.
2.4. Immunocytochemical staining
For immunocytochemical staining, SK-N-SH or SK-N-SH-MJD78
cells were ¢xed in 4% paraformaldehyde for 20 min, following by
three washes in phosphate-bu¡ered saline (PBS), 20 min incubation
with 1% Triton X-100 in PBS to permeabilize the cells, 20 min in-
cubation with 2% bovine serum albumin in PBS to block non-speci¢c
binding, and then incubation with each antibody at 4‡C overnight.
After washing with PBS, immunodetection was performed with bio-
tinylated anti-mouse immunoglobulin followed by peroxidase-labeled
streptavidin (BioGenex). Finally, the reactants were developed with
3,3P-diaminobenzidine (Dako). Counterstaining was performed using
hematoxylin. Visible aggregate formation was determined using a
Zeiss £uorescence microscope equipped with a digital camera. The
percentage of cells exhibiting aggregates was calculated. In each ex-
periment at least 30 cells were counted per dish, with a minimum of
four dishes utilized for each time point.
2.5. Cell toxicity studies and analysis of cell survival
SK-N-SH and SK-N-SH-MJD78 cells were maintained in DMEM
medium containing 10% FBS and then were prepared at a concentra-
tion of 1U105 cells/ml, 100 Wl of which was added to each well of
96-well plates. One day after seeding, cells were changed to medium
containing no serum for 24 h and then TBH (0 WM, 1 WM or 3 WM)
was added to the cells. Appropriate controls were included with only
water added to cells. After 12, 24, 36, 48, 60 h, cell viability was
determined by a modi¢ed 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenylte-
trazolium bromide (MTS) assay (cell titer 96, Promega) as described
previously [31,32]. At least six cultures were utilized for each time
point. After 4 h of incubation, optical densities were measured at
490 nm. Results were expressed as the percentage of controls.
2.6. Western blot analysis of protein levels
In brief, cell lysates containing 20^30 Wg of protein were loaded
onto 12% sodium dodecyl sulfate (SDS)^polyacrylamide gels. Re-
solved proteins were electrophoretically transferred onto nitrocellulose
membranes. After blocking the membrane with 5% non-fat milk in
NaCl/Pi/0.1% Tween 20 for 1 h at room temperature, all antibody-
binding reactions were performed in the same bu¡er supplement with
1% non-fat milk at 4 ‡C overnight for primary antibodies and at room
temperature for 1 h for secondary antibodies coupled to horseradish
peroxides. The signal was detected by the enhanced chemilumines-
cence supersignal system (Pierce, Rockford, IL, USA). Monoclonal
antibody against L-actin was included in the experiments as an inter-
nal control.
2.7. Two-dimensional gel electrophoresis
We applied 500 Wg of each cell lysate at the cathodic end of the
immobilized pH gradient gel (IPG) strips (pH 3^10, 13 cm, Pharmacia
Biotech, Uppsala, Sweden), and isoelectrophocusing (IEF) was con-
ducted for 10^16 h (13 000^20 100 V/h) using Electrophoresis Power
Supply ESP 3500 XL (Pharmacia Biotech). Upon completion of IEF,
the IPG strips were equilibrated in 50 mM Tris^HCl, pH 8.8, 6 M
urea, 30% glycerol, 2% (w/v) SDS, 15.4 mg/ml dithiothreitol, and
0.0125% bromophenol blue for 15 min. The strips were stored at
80‡C or used immediately. Gradient SDS^polyacrylamide gels (5^
20%, 17 cmU20 cmU1 mm) were employed for the two-dimensional
separation in a PROTEAN II xi 2D cell (Bio-Rad, Hercules, CA,
USA), and run at 40 mA constant current for 5 h. The two-dimen-
sional gels were stained with Coomassie brilliant blue G-colloidal.
Destaining was performed by soaking the gels in 10% acetic acid
and 25% methanol solution for 60 s, then in 25% methanol solution
for 24 h at room temperature. The two-dimensional maps of cells were
compared by using Z3 (Compugen) or Melanie III 2D polyacrylamide
gel electrophoresis software (Genebio, Geneva, Switzerland) and
checked manually. Proteins were recovered by punching out spots
with Pipet Tips (volume: 100^1000 Wl). Protein spots were punched
for later mass spectrometry analysis.
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2.8. In-gel enzymatic digestion
The gel pieces were washed twice with 30 Wl of 25 mM ammonium
bicarbonate/acetonitrile (1/1 v/v, pH 8.5) and followed by dehydration
with acetonitrile for several times. After complete drying in a speed
vac for 15 min, gel pieces were placed overnight at 37‡C in a digestion
bu¡er containing 50 ng/Wl sequencing grade trypsin (Promega, Mad-
ison, WI, USA) in 25 mM ammonium bicarbonate. The obtained
peptides were extracted with 10 Wl of water^acetonitrile (1/1 v/v,
0.5% tri£uoroacetic acid (TFA)) for three times. The combined frac-
tions were lyophilized to dryness. The peptides were further desalted
with Ziptip (Millipore, Bedford, MA, USA) and dissolved in 10 Wl of
water^acetonitrile (1/3 v/v, 0.1% TFA).
2.9. Tandem electrospray ionization mass spectrometry (ESI-MS/MS)
MS/MS sequence of peptides generated by in-gel digestion was
performed by high-performance liquid chromatography-coupled
nano-ESI on a Q-TOF II mass spectrometer (Micromass, Manchester,
UK) equipped with a Z-spray source. The peptides were separated on
a 150-mm id/10-mm length C18 RP column. Elution of peptides was
carried out with a gradient solution of 90% acetonitrile over 25 min at
a £ow rate of 200 nl/min. The eluted peptides were analyzed by se-
quencing with automated MS-to-MS/MS switching protocol. MS ac-
quisitions were performed within the mass range of 400^2000 m/z and
MS/MS within 50^3500 m/z. The spectral data were processed using
MassLynx 3.4 software to obtain centroid MS/MS data. The resulting
PKL ¢les were submitted to the MASCOT (http://www.matrixscien-
ce.com) search engine that was set to query NCBI database to obtain
the corresponding protein identity.
2.10. Statistical analysis
All bands were quanti¢ed by laser densitometry. All values were
expressed as meansTS.E.M. The analysis of variance with subsequent
Student’s t-test was employed to determine the signi¢cance of di¡er-
ences in comparisons. Values of P6 0.05 were considered statistically
signi¢cant.
3. Results
3.1. Expression of expanded ataxin-3 in SK-N-SH cells
Although an inducible rat mesencephalic CSM14.1 clonal
cell line expressing expanded human full-length ataxin-3 was
previously reported [27], a human neuronal cell line expressing
mutant ataxin-3 would be valuable to study the e¡ect of mu-
tant ataxin-3. Therefore, human SK-N-SH cells, containing
endogenous normal ataxin-3 with 26 glutamine residues,
were used as the parental cells. SK-N-SH cells were stably
transfected with full-length poly(Q) expanded MJD construct
(pCDNA3-HAMJD78), using G418 (500 Wg/ml) to select sta-
bly transfected cells. A stable clone, named SK-N-SH-
MJD78, was obtained after 3 months selection. Expression
of the exogenous mutant ataxin-3 in SK-N-SH-MJD78 was
con¢rmed by Western blot analysis and immunocyto-
chemistry. Antibodies against ataxin-3 or HA epitope were
used for blotting because the pCDNA3-HAMJD78 constructs
were HA-tagged. A representative Western blot is shown in
Fig. 1A. A band of V62 kDa was visible on a 6% SDS^
polyacrylamide gel in the transfected cells (lane 2) represent-
ing the expression of HA-tagged expanded ataxin-3, whereas
the parental SK-N-SH cells did not show the signal (lane 1).
In addition, when immunoblotted by monoclonal antibody to
ataxin-3, the results showed that both normal and expanded
(26 and 78 residues) ataxin-3 could be visible in the trans-
fected cells (Fig. 1B, lane 2) compared with only one normal
signal (26 residues) in parental cells (Fig. 1B, lane 1). It was
noted that another immunoreactive protein was also seen as a
doublet at the size of 62 kDa corresponding to the length of
the CAG expansion. The latter was also probed with 1C2
(data not shown). The extra band of expanded ataxin-3 may
indicate alternatively spliced transcripts existing or the cleav-
age of HA-tag in the stably transfected neuronal cells.
From immunocytochemical study, full-length ataxin-3 with
expanded repeat (78 residues) usually di¡usely distributed in
the cytoplasm of transfected cells (Fig. 2B), compared with
very little background staining in the control cells (Fig. 2A).
Less than 1% of the transfected cells showed NIs (Fig. 2C)
and both SK-N-SH and SK-N-SH-MJD78 showed similar
morphology. Size and stability of the exogenously expressed
ataxin-3 was further con¢rmed on lysates obtained from cells
at the 11th, 30th and 80th passages (data not shown). The
intensity of the immunoreactive band in cells bearing the mu-
tant ataxin-3 did not signi¢cantly alter with time in vitro, up
to the 80th passage. In addition, the size of the immunoreac-
tive band remained the same, indicating that the poly(Q) re-
peat was stably replicated in SK-N-SH-MJD78 cells. To date,
SK-N-SH-MJD78 cells have been passaged for over 80 gen-
erations under basal conditions without apparent loss of phe-
notypes. The transfected cells before the 60th passage were
used for the following experiments.
3.2. Wild-type and mutant MJD di¡erentially a¡ect cell
viability upon TBH treatment
Due to the late-onset feature of the disease, we hypothe-
sized that oxidative stress might be contributory to the pro-
gression of the disease. To test this hypothesis, the oxidative
stress derived from exogenous sources was evaluated in our
cellular model. TBH, widely used as a mild oxidative reagent
in di¡erent cellular models [33], was used to assess the oxida-
tive tolerance of cells carting mutant ataxin-3. While neuronal
Fig. 1. Detection of expressed wild-type and expanded ataxin-3.
A: Western blot analysis of the parental SK-N-SH cells (lane 1)
and stably transfected SK-N-SH-MJD78 (lane 2). Western blot
probed with anti-HA and anti-L-actin antibodies. B: Western blot
analysis of the parental SK-N-SH cells (lane 1) and stably trans-
fected SK-N-SH-MJD78 (lane 2). Monoclonal anti-ataxin-3 was
used in the blotting.
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cells were exposed in vitro to TBH from 1 to 3 WM, quanti-
tations of the e¡ects by MTS assays revealed signi¢cant di¡er-
ences in cell viability between cells with (Fig. 3A) and without
(Fig. 3B) expanded ataxin-3. Fig. 4B shows that cultures of
the parental SK-N-SH cells did not exhibit a dose-dependent
decrease of cell viability after 1 and 3 WM TBH treatment.
However, this decrease was evident in SK-N-SH-MJD78 cells
(Fig. 3A). It was noted that increased sensitivity to TBH up to
24 h treatment in the transgenic cell line compared to control
cells. The 36 and 48 h values rather indicated some kind of
proliferation phenomenon of both controls and transgenic
cells. It is possible that TBH was not stable after 24 h treat-
ment or some intrinsic antioxidative protection properties
might have been induced.
3.3. Protein expression of HSP27 dramatically decreased in the
presence of expanded ataxin-3
Meanwhile, because the low percentage of NIs was ob-
served in SK-N-SH-MJD78, our cellular model was valuable
to study the early events of MJD. Comparative proteome
analysis was performed to distinguish the putative gene ex-
pression alterations between cells with and without expanded
ataxin-3. One candidate spot with a signi¢cant expression dif-
ference (Fig. 4A) was excised, trypsin-digested and analyzed
by ESI-MS/MS. Mass spectra corresponding to tryptic digest
of this protein are shown in Fig. 4B. The MS/MS data was
matched to HSP27 in NCBI database using the MASCOT
search engine (http://www.matrixscience.com). The amino se-
quence of HSP27 is shown in Fig. 4B and the essential pep-
tides used for MS/MS sequencing were underlined. MS/MS
pro¢le of the investigated peptide 582.24 (2+) clearly indicated
the amino acid sequence as LFDQAFGLPR, which is charac-
teristic to HSP27 (Fig. 4C). In order to con¢rm this observa-
tion, Western blot analysis was performed using monoclonal
Fig. 3. SK-N-SH-MJD78 cells are more susceptible to oxidative
stress by TBH. Characteristics of cell death induced by expanded
ataxin-3 under TBH treatment. SK-N-SH-MJD78 (A) and SK-N-
SH cells (B) were treated with TBH (1 or 3 WM) for various times
at 37‡C. Cell viability was estimated by the MTS assay. The values
were normalized to 100% using the respective control cells not
treated with TBH. Data from one representative experiment (n=6)
with standard errors are shown.
Fig. 2. Immunocytochemical analysis of expressed wild-type and ex-
panded ataxin-3. A: SK-N-SH (magni¢cation: 1000U). B: SK-N-
SH-MJD78 cells were labeled with monoclonal anti-HA antibody
(magni¢cation: 400U). C: About 1% of the stably transfected cells
showed NIs with monoclonal anti-ataxin-3 antibody. The arrow in-
dicates the NI body (magni¢cation: 1200U).
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antibody against HSP27. A representative Western blot is
shown in Fig. 5A. The results demonstrated that the protein
levels of HSP27 in the stably transfected cells signi¢cantly
decreased (Fig. 5A, lane 2) compared with that of the parental
cells (Fig. 5A, lane 1). A quantitative assessment of the per-
centage of protein expression revealed that HSP27 in the sta-
bly transfected cells retained only about 20% of that of the
parental cells (Fig. 5B). This observation was further con-
¢rmed by imunocytochemical staining using mouse monoclo-
nal antibody against HSP-27. As shown in Fig. 6, signi¢cant
positive staining was observed in the parental cells (Fig. 6A)
compared with very weak staining in cells containing ex-
panded ataxin-3 (Fig. 6B). Meanwhile, lymphoblastoid cell
lines (LCLs) from two MJD patients and one normal individ-
ual were used for comparison. Western blot analysis demon-
strated that both normal and mutant ataxin-3 were expressed
Fig. 4. Identi¢cation of a decreased expression of HSP27 via 2-DE followed by MS/MS sequencing. A: Partial 2D images of proteins from cells
with and without expanded ataxin-3. The arrows indicate the signi¢cantly di¡erential expression of HSP27. B: The peptide identi¢ed by tandem
mass sequencing is shown underlined within the amino acid sequence of HSP27. C: A MS/MS spectrum of the investigated peptide 582.24 (2+)
is shown. The sequence interpretation was performed using y-ions and b-ions. The MS/MS data was matched to HSP27 in the NCBI database
using the MASCOT search engine (http://www.matrixscience.com).
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in samples from two patients (Fig. 7A, lanes 2 and 3), com-
pared with only one normal ataxin-3 in the control LCL (Fig.
7A, lane 1). We further con¢rmed a signi¢cant reduction of
HSP27 in two MJD LCLs (Fig. 7B, lanes 2 and 3), compared
with that from a normal individual (Fig. 7B, lane 1). Further-
more, we compared the expression of other HSPs in our neu-
ronal cellular model to understand whether the reduction of
HSP27 was due to a common e¡ect on heat shock response.
By contrast, other stress associated HSPs, namely HSP60,
70 and 90 examined by Western blot analysis, remained un-
a¡ected in SK-N-SH-MJD78 cells (data not shown). These
results indicated that the altered protein expression of
HSP27 was speci¢c in the cellular model. We next determined
whether this reduction in HSP27 was due to transcriptional
repression of HSP27 gene. Semiquantitative reverse transcrip-
tion-polymerase chain reaction (RT-PCR) and microarray
analysis indicated that the di¡erences we observed in the pro-
tein levels were not due to transcriptional defects (data not
shown).
4. Discussion
In the present study, neuronal SK-N-SH-MJD78 cells, sta-
bly expressing expanded ataxin-3, were established to analyze
the role(s) of mutant ataxin-3 in human neuronal cells. In
contrast to transient transfection or inducible polyglutamine
expression, cells in the present study did not undergo a rapid
form of cell death under basal conditions. The clonal cells
expressing expanded full-length ataxin-3 showed less than
1% intranuclear aggregates (Fig. 2C), indicating that the phys-
iological condition of our cellular model was more likely to
mimic the early stage of this late-onset disease. Although no
increased cell death was observed in the SK-N-SH-MJD78
cells for more than 80 passages, we could not rule out the
possibility that cells may have compromised viability. Many
mammalian cellular models of poly(Q) disease have shown
that overexpression of poly(Q) protein containing a poly(Q)
expansion resulted in toxicity/cell death [24,34]. Chemicals
and conditions that damage proteins, promote protein mis-
folding, or inhibit protein processing triggered the onset of
protective homeostatic mechanisms resulting in ‘stress re-
sponses’ in mammalian cells. It was reported that rat pheo-
chromocytoma PC12 cells stably expressing polyglutamine ex-
pansion were more vulnerable to exogenous stress [34]. In this
study, our results demonstrated that cells with expanded atax-
in-3 were more susceptible to exogenous oxidative stress than
the parental cells, indicating that these cells had weak protec-
tion e¡ects upon the extracellular oxidative stress.
In an attempt to determine whether the expression of ex-
panded ataxin-3 altered gene expression that may be impor-
tant in the neurotoxicity observed in MJD, comparative pro-
Fig. 6. Immunocytochemical analysis of expressed HSP27. SK-N-SH
and (A) SK-N-SH-MJD78 (B) were labeled with monoclonal anti-
HSP27 antibodies (magni¢cation: 1000U).
Fig. 5. HSP27 expression in the cells stably transfected with ex-
panded ataxin-3 or the parental cells. A: Western blot analysis of
HSP27 proteins. Untransfected SK-N-SH human neuroblastoma
cells (lane 1) and the cells stably transfected with expanded ataxin-3
(lane 2) were cultured in complete medium. Cell lysates were elec-
trophoresed, Western blotted and probed with anti-HSP27 antibody
and anti-L-actin antibody. B: HSP-27 expression in the stably trans-
fected cells relative to the control. n=4; **P6 0.0001.
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teome analysis was performed and a dramatic expression dif-
ference in HSP27 was identi¢ed. Western blots further dem-
onstrated that the signi¢cant reduction of HSP27 was ob-
served in both neuronal cells and non-neuronal cells
expressing expanded MJD. It ruled out the possibility that
the reduction of HSP27 was the result from overexpression
of a certain protein in SK-N-SH cells. In addition, it was
worthy noting that the reduced HSP27 expression was not
due to transcriptional dysregulation, as indicated through
semiquantitative RT-PCR and microarray analysis (data not
shown). This observation ruled out the possibility that HSP27
gene may be disrupted by the transgene in our stable cell line.
It was shown that HSP27 was regulated at di¡erent levels
along with the expression, including transcriptional, transla-
tional and posttranslational [35]. Further studies will be re-
quired to address the mechanism underlying the reduced pro-
tein level of HSP27 in the disease model.
HSP27 was reported to protect cells against oxidative stress
and have anti-apoptotic properties in neuronal survival
[16,17,24,36]. The expression of HSP27 led to a decrease in
ROS and to an increase in glutathione [36,37]. Recently, it
was reported that mutant huntingtin caused increased levels
of ROS in neuronal cells and transiently transfected HSP27
suppressed the increased levels of cellular ROS without inter-
fering poly(Q) aggregation [24]. Therefore, it is possible that a
reduction of HSP27 in the presence of expanded ataxin-3
resulted in an increase of ROS in the cellular model. However,
we cannot rule out the possibility that the reduced level of
HSP27 may be involved in other pathway(s) that lead to cell
death in the pathogenesis of MJD. It was reported that
HSP27 inhibits the mitochondrial death pathway by binding
to and inhibiting apoptosome formation [13]. In addition, the
phosphorylated dimers of HSP27 were demonstrated to inter-
act with Daxx and prevent the interaction of Daxx with both
Ask1 and Fas, therefore blocking Daxx-mediated apoptosis
[38]. It is possible that HSP27 has a speci¢c target in a key
apoptotic signaling or execution pathway, which was sup-
ported earlier by the report that HSP27 can prevent activation
of pro-caspase 9 after etoposide treatment and can inhibit
apoptosis induced by activation of the Fas receptor [36,39].
Our next works will be addressing which pathway that HSP27
may be involved in the molecular pathogenesis of MJD.
Even though we do not yet understand the mechanism re-
sponsible for the signi¢cant reduction of HSP27, this obser-
vation in the early disease stage suggested that the loss of
HSP27 protection activity together along with aging might
ultimately lead to cell death. However, we cannot exclude
the possibility that other cellular proteins involving signal
transduction and/or apoptosis pathways also play important
roles in the pathogenesis of MJD. It is important to note that
the neuronal cells contained the ability to withstand the exis-
tence of expanded ataxin-3 for prolonged periods without ap-
parent adverse e¡ects in our cellular model. It is likely that
cells underwent genetic or biochemical changes that allowed
them to cope with expanded full-length ataxin-3 in the early
stage of the disease. Further analysis of the roles of expanded
ataxin-3 will help to better understand its physiological func-
tions and how the poly(Q) expansion in the mutant protein
interferes with those and/or other activities.
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